By offering the prescribed medication at the preprogrammed time, as well as monitoring and support, the service aims to increase medication adherence among seniors and chronically ill patients. This could improve their health and quality of life, while reducing avoidable hospital stays, adverse events and healthcare costs, and supporting healthcare organizations.
Each time medication is due, the dispenser automatically reminds the person, checks it is the right medication at the right time and then releases and opens individual pouches according to the patient’s prescribed regimen. This motivates the patient to adhere to personal medication plans and minimizes the risk of taking the wrong medication or dose. The solution monitors medication usage and remotely alerts nursing staff when medication is not taken, helping to streamline the normally time-consuming task of medication management and allowing them to focus on additional care issues.
"Technology-enabled care at home will play an increasingly important role in helping care providers cope with the pressing challenges presented by rising numbers of people with chronic conditions," said Henk Valk, General Manager Philips Healthcare Benelux. "For more than a decade, Philips has been a pioneer in the home healthcare market in the Netherlands, and we are continuously looking to expand our offering through collaborations, innovative technologies and services that can make a difference where it matters for patients, their families and healthcare providers."
"Poor medication adherence is relatively common and has dramatic effects on individual and population-level health," said Dick Herfst, CEO of ZZG zorggroep, a Dutch home care, elderly care and nursing home organization that is already using the initial version of the service. "Helping clients take their medication correctly and in time is an important, but often time-consuming task for our community nurses. With the help of this medication dispensing service, we see clients are more compliant and independent while their relatives feel more comfortable."
As people live longer, chronic illness is increasingly common and places a growing burden on healthcare systems. Home healthcare provides new cost effective ways to support seniors and chronically ill patients while retaining an independent lifestyle. Studies show that around 50% of medication for chronic disease is not taken as prescribed [1]. Each year in the Netherlands, 19.000 potentially avoidable hospitalizations involve elderly people who took their medication incorrectly, adding up to an annual financial burden of EUR 85 million [2].
The home medication dispensing service for the Benelux differs from the medication dispensing service that Philips already offers in the United States, as it is based on a medication pouches system that is standardized and broadly available in the Netherlands. To bring the solution to market in the Netherlands, Philips is collaborating with the Dutch pharmaceutical telehealth company Innospense, that initially developed the integrated medication dispensing service, and is assisted by e-health implementation provider Focus Cura. Philips will also work with pharmacies to ensure the patient’s prescribed regimen is synchronized with the intelligent dispensing device in the patient's home.
Related news articles:
- Philips Healthcare's Profile
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 114,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.
1. Closing the Quality Gap Series: Medication Adherence Interventions: Comparative Effectiveness Hospitals Admissions
2. Related to Medication (HARM study), Division of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, 2006